We aim to develop a simple prognostic tool for rheumatic heart disease. In the first phase of the project we aim to identify a set of
peptides that induce a pro-inflammatory cytokine response from T cells isolated from rheumatic heart disease patients in Salvador, Brazil. The development of a prognostic tool which is inexpensive, simple and portable will help neglected populations get the appropriate treatment and care necessary to prevent severe outcomes from this preventable and neglected disease.